It is widely accepted that the myocardial induction of p53 is a critical event for the disruption of the cardiomyocyte‐vasculature interaction, leading to the onset of heart failure (Gogiraju et al., 2015; Mak et al., 2017; Men et al., 2021). This evidence concerns the gene TP53 and heart failure.